2022 Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP) Group Acute Leukemia Working Party (ALWP) 1st listed author Eleni Gavriilaki Journal Bone Marrow Transplant.
2022 Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2022 Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Alexandros Spyridonidis Journal Bone Marrow Transplant.
2022 Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modelling Group Chronic Malignancies Working Party (CMWP) 1st listed author Sarah Lawless Journal Haematologica.
2022 STEM CELL TRANSPLANTATION IN PATIENTS AFFECTED BY SHWACHMAN- DIAMOND SYNDROME: EXPERT CONSENSUS AND RECOMMENDATIONS FROM THE EBMT SEVERE APLASTIC ANAEMIA WORKING PARTY Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Simone Cesaro Journal Transplant Cell Ther.
2022 Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT) Group Acute Leukemia Working Party (ALWP) 1st listed author Enrico Maffini Journal Bone Marrow Transplant.
2022 The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency Group Inborn Errors Working Party (IEWP) 1st listed author Jerold Jeyaratnam Journal Pediatr Rheumatol Online J.
2022 Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2022 Impact of the addition of antithymocyte globulin to post-transplant cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplant cyclophosphamide alone in acute myeloid leukemia: a retrospective study on behalf of the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Giorgia Battipaglia Journal Transplant Cell Ther.
2022 Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation Group Transplant Complications Working Party (TCWP) Other society 1st listed author Rachel Phelan Journal Bone Marrow Transplant.
2022 Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022 Group Acute Leukemia Working Party (ALWP) Severe Aplastic Anaemia Working Party (SAAWP) Autoimmune Diseases Working Party (ADWP) Chronic Malignancies Working Party (CMWP) Cellular Therapy & Immunobiology Working Party (CTIWP) Inborn Errors Working Party (IEWP) Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) Lymphoma Working Party (LWP) Paediatric Diseases Working Party (PDWP) 1st listed author John A Snowden Journal Bone Marrow Transplant.
2022 Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT) Group Autoimmune Diseases Working Party (ADWP) 1st listed author Tobias Alexander Journal Bone Marrow Transplant.